chevron_leftBack
As of 7 June 2026, Intech Biopharm Corp. has a market cap of $101.52M USD, ranking #25454 globally and #1379 in Taiwan.
It ranks #2287 in the Healthcare sector, and #829 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$101.52MUSD
3.19B TWD
Enterprise Value
$131.91MUSD
4.17B TWD
Revenue (TTM)
$3.42MUSD
107.53M TWD
EBITDA (TTM)
-$8.69MUSD
-274.52M TWD
Net Income (TTM)
-$12.37MUSD
-389.03M TWD
EBITDA Margin
-255%
PS Ratio
29.7
PB Ratio
2.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Manish Chawla
open_in_new
Employees
90
Founded
2010
Website
intechbiopharm.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.6% | -9.1% | -3.7% | -13% | 7.1% | -1.4% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
6461
益得生物科技股份有限公司
ISIN: TW0006461007
Shares Out.:
Shares Outstanding:
178.352M1
Shares Float:
90.58M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
17.90 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Intech Biopharm Corp.
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
8K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
2K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.55M
812%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$809.3M
697%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$789.12M
677%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$584.14M
475%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
750K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
539K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
355K%
|
97.4
|
|
SIX: RO
|
$324.68B
320K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
285K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
273K%
218.9B CHF
|
20.5
|
chevron_leftBack